Esperion Therapeutics Inc.


Market Cap$467.97M

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Esperion Therapeutics Inc.Esperion Therapeutics Inc.-5.40%29%2.9-1.9

Current Fair Value

285.3% upside

Undervalued by 285.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$467.97 Million
Enterprise Value$790.23 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.66
Outstanding Shares189,460,293
Avg 30 Day Volume6,781,695


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-5.41
Price to Sales2.89
Price to Book Ratio-1.45
Enterprise Value to Revenue3.44
Enterprise Value to EBIT-22.78
Enterprise Value to Net Income-10
Total Debt to Enterprise0.69
Debt to Equity-1.87

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Esperion Therapeutics Inc.

CEO: Timothy Mayleben